Stay updated with breaking news from Nyse Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UiPath (NYSE:PATH – Free Report) had its target price increased by Mizuho from $18.00 to $22.00 in a research report report published on Friday, Benzinga reports. The firm currently has a neutral rating on the healthcare company’s stock. A number of other analysts also recently commented on the company. Needham & Company LLC reiterated a […]
UiPath (NYSE:PATH – Free Report) had its price target boosted by Needham & Company LLC from $20.00 to $25.00 in a report released on Friday morning, Benzinga reports. The brokerage currently has a buy rating on the healthcare company’s stock. Several other equities analysts have also recently weighed in on PATH. Mizuho raised their price […]
UiPath (NYSE:PATH – Free Report) had its target price raised by BMO Capital Markets from $19.00 to $24.00 in a report published on Friday, Benzinga reports. The firm currently has a market perform rating on the healthcare company’s stock. A number of other brokerages have also issued reports on PATH. Canaccord Genuity Group lifted their […]
UiPath Inc. (NYSE:PATH – Get Free Report)’s share price gapped up prior to trading on Friday after JPMorgan Chase & Co. raised their price target on the stock from $19.00 to $22.00. The stock had previously closed at $19.76, but opened at $22.61. JPMorgan Chase & Co. currently has a neutral rating on the stock. […]
River & Mercantile Asset Management LLP purchased a new position in UiPath Inc. (NYSE:PATH – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 32,990 shares of the healthcare company’s stock, valued at approximately $546,000. Other large investors have also recently modified their […]